
Deinove acquires FDA-Fast Track antibiotic compound
MCB3837 is a water-soluble injectable small-molecule prodrug of the active substance MCB3681, which is being developed for the treatment of...

Roche reports 5 deaths after dosing of Hemlibra
Roche’s US arm Genentech, which received FDA market approval for the bispecific antibody co-developed with Chugai last December (EU: February...

Protein keeps breast cancer metastases at bay
Three years ago, the team of Roger Gomez at IRB Barcelona discovered that certain mutations in the MAF gene of breast cancer patients correlated with...

New target could minimise transplant risks
Intestinal GVHD, in which donor T cells attack host tissue, is associated with a poor prognosis. A research group headed by Kai Hildner at University...

AML: Sorafenib boosts graft-versus-leukemia activity
"Originally, sorafenib was only given to patients to slow the progression of the disease. We then found that the cancer disappears in patients...

PharmaMar in licence deal with Seattle Genetics
Under the deal, Seattle Genetics will get the exclusive worldwide rights to some proprietary sea-derived toxic payloads of PharmaMar for the...

MorphoSys files registration for ADS offering
Experts expect MorphoSys to raise up to US$150m in the form of ADS at Nasdaq. Goldman Sachs & Co. LLC, J.P. Morgan Securities LLC and Leerink...